Transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: A prospective comparative study

Annals of Surgical Oncology

Volumn 18, Issue 2, 2011, Pages 413-420

  Luo, Jun ^a,b   Guo, Rong Ping ^a,b   Lai, Eric C H ^c   Zhang, Yao Jun ^a,b   Lau, Wan Yee ^c   Chen, Min Shan ^a,b   Shi, Ming ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^c and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

EPIRUBICIN; GELATIN SPONGE; GELFOAM; IODINATED POPPYSEED OIL; LOBAPLATIN; MITOMYCIN C;

ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CANCER SURVIVAL; CHEMOEMBOLIZATION; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; FEMALE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PORTAL VEIN TUMOR THROMBOSIS; PROGNOSIS; SURVIVAL RATE; TRANSARTERIAL CHEMOEMBOLIZATION; TUMOR THROMBUS; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PORTAL VEIN; PROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; VENOUS THROMBOSIS; YOUNG ADULT;

EID: 79951556637     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1321-8     Document Type: Article

References (26)

1. HB El-Serag KL Rudolph 2007 Hepatocellular carcinoma: epidemiology and molecular carcinogenesis Gastroenterology 132 7 2557 2576 1:CAS:528: DC%2BD2sXnvFOgsrw%3D 10.1053/j.gastro.2007.04.061 17570226 (Pubitemid 46890874)
2. YH Kuo SN Lu CL Chen, et al. 2010 Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosis Eur J Cancer 46 4 744 751 10.1016/j.ejca.2009.12.018 20060710
3. Lau WY, Lai EC, Yu SC. Management of portal vein tumor thrombus. In: Wy L, ed. Hepatocellular carcinoma. Singapore: World Scientific Publishing Co. Pte. Ltd.; 2008, pp 1-24.
4. CM Lo H Ngan WK Tso, et al. 2002 Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma Hepatology 35 5 1164 1171 1:CAS:528:DC%2BD38XktF2hu7w%3D 10.1053/jhep.2002.33156 11981766 (Pubitemid 34454013)
5. JM Llovet MI Real X Montaña, et al. 2002 Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Lancet. 359 1734 1759 10.1016/S0140-6736(02)08649-X 12049862 (Pubitemid 34607087)
6. K Takayasu S Arii I Ikai, et al. 2006 Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients Gastroenterology 131 2 461 469 1:CAS:528:DC%2BD28XpsFyks7Y%3D 10.1053/j.gastro.2006.05.021 16890600 (Pubitemid 44142456)
7. JW Chung JH Park JK Han, et al. 1996 Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization Radiology 198 1 33 40 1:STN:280:DyaK287itlWguw%3D%3D 8539401
8. J Bruix M Sherman 2005 Management of hepatocellular carcinoma Hepatology 42 5 1208 1236 10.1002/hep.20933 16250051 (Pubitemid 43112690)
9. Kothary N, Weintraub JL, Susman J, Rundback JH. Transarterial chemoembolization for primary hepatocellular carcinoma in patients at high risk. J Vasc Interv Radiol. 2007;18(12):1517-26; quiz 1527. (Pubitemid 350151875)
10. KM Kim JH Kim IS Park, et al. 2009 Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion J Gastroenterol Hepatol 24 5 806 814 10.1111/j.1440-1746.2008.05728.x 19207681
11. Lee HS, Kim JS, Choi IJ, et al. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study. Cancer. 1997;79(11):2087-94. (Pubitemid 27227372)
12. M Shi JA Chen XJ Lin, et al. 2010 Transarterial chemoembolization as initial treatment for unresectable hepatocellular carcinoma in southern China World J Gastroenterol 16 2 264 269 10.3748/wjg.v16.i2.264 20066748
13. JH Wang CS Changchien TH Hu, et al. 2008 The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma-survival analysis of 3892 patients Eur J Cancer 44 7 1000 1006 10.1016/j.ejca.2008.02.018 18337087
14. JW Jang SH Bae JY Choi, et al. 2007 A combination therapy with transarterial chemo-lipiodolization and systemic chemo-infusion for large extensive hepatocellular carcinoma invading portal vein in comparison with conservative management Cancer Chemother Pharmacol 59 1 9 15 1:CAS:528:DC%2BD28Xht1entL%2FP 10.1007/s00280-006-0239-0 16614848 (Pubitemid 44796097)
15. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol. 2001;35(3):421-30. (Pubitemid 32844200)
16. N Ueno A Sasaki T Tomiyama, et al. 1997 Color Doppler ultrasonography in the diagnosis of cavernous transformation of the portal vein J Clin Ultrasound 25 5 227 233 1:STN:280:DyaK2svlvFegsA%3D%3D 10.1002/(SICI)1097-0096(199706)25: 5<227::AID-JCU2>3.0.CO;2-F 9314103 (Pubitemid 27190734)
17. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92(3):205-16. (Pubitemid 30099779)
18. AO Chan MF Yuen CK Hui, et al. 2002 A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma Cancer 94 6 1747 1752 10.1002/cncr.10407 11920537 (Pubitemid 34241113)
19. M Shi RP Guo XJ Lin, et al. 2007 Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial Ann Surg 245 1 36 43 10.1097/01.sla.0000231758.07868.71 17197963 (Pubitemid 46035433)
20. MS Chen JQ Li Y Zheng, et al. 2006 A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma Ann Surg 243 3 321 328 10.1097/01.sla.0000201480.65519. b8 16495695 (Pubitemid 43327762)
21. WY Lau TW Leung BS Lai, et al. 2001 Preoperative systemic chemoimmunotherapy and sequential resection for unresectable hepatocellular carcinoma Ann Surg 233 2 236 241 1:STN:280:DC%2BD3M7ls1Smtg%3D%3D 10.1097/00000658-200102000-00013 11176130 (Pubitemid 32106078)
22. WY Lau SK Ho SC Yu, et al. 2004 Salvage surgery following downstaging of unresectable hepatocellular carcinoma Ann Surg 240 2 299 305 10.1097/01.sla.0000133123.11932.19 15273555 (Pubitemid 38963022)
23. WY Lau EC Lai 2007 Salvage surgery following downstaging of unresectable hepatocellular carcinoma-a strategy to increase resectability Ann Surg Oncol 14 12 3301 3309 10.1245/s10434-007-9549-7 17891443 (Pubitemid 350160117)
24. WY Lau SC Yu EC Lai TW Leung 2006 Transarterial chemoembolization for hepatocellular carcinoma J Am Coll Surg 202 1 155 168 1:STN:280: DC%2BD2MnovVKkuw%3D%3D 10.1016/j.jamcollsurg.2005.06.263 16377509 (Pubitemid 41831485)
25. J Welink E Boven JB Vermorken, et al. 1999 Pharmacokinetics and pharmacodynamics of lobaplatin (D-19466) in patients with advanced solid tumors, including patients with impaired renal of liver function Clin Cancer Res 5 9 2349 2358 1:CAS:528:DyaK1MXmsFyjs7w%3D 10499604 (Pubitemid 29437313)
26. B Zhou H Shan KS Zhu, et al. 2010 Chemoembolization with lobaplatin mixed with iodized oil for unresectable recurrent hepatocellular carcinoma after orthotopic liver transplantation J Vasc Interv Radiol 21 3 333 338 10.1016/j.jvir.2009.11.006 20116286